Kewaunee Scientific (KEQU) reported fiscal Q4 adjusted earnings late Tuesday of $1.14 per diluted share, down from $1.95 a year earlier.
Net sales for the three months ended April 30 was $71.4 million, down from $77.1 million a year earlier.
FactSet estimates were not readily available.